Meibomian Gland Dysfunction and Blepharitis.
Antibiotics are often used systemically to prevent Blepharitis eye infections in dry eye patients. Blepharitis and Meibomian Gland Dysfunction often go hand in hand.
are several studies concerning the use of topical azithromycin in
ocular surface diseases. . Dr. Gary Foulks and his group at the
University of Louisville compared the effectiveness of topical
azithromycin versus oral doxycycline therapy in meibomian gland
dysfunction and Belpharitis.
Twenty-two subjects were treated with topical
azithromucin solution for one month and seven subjects were treated
with oral doxycycline for two months. The study concluded that while
both topical azithromycin and oral doxycycline improved clinical signs
and symptoms of meibomian gland dysfunction, the "response to
azithromycin is more rapid and more robust than doxycycline."
another study from the Ohio State University School of Optometry
evaluated the efficacy of a four-week treatment with topical 1.0%
azithromycin solution versus rewetting drops in patients with contact
lens related dry eye. An over two-hour improvement in comfortable
contact lens wear time was noted throughout the four-week study period
with azithromycin solution use.
being a chronic inflammation of the eye lid goes hand in hand with
chronic dry eyes. Here is how TheraLife Eye can help!
How can TheraLife Eye Help?
Eye is an all natural oral formula that treats from inside out! It is
uniquely formulated to restore normal cell functions to tear secretion
glands intra-cellularly for sustainable, long lasting relief. Clinically
proven to work for 80% of first time users.
To learn more
Get discount packages
Watch a video
Call us toll free 1-877-917-1989
International (650) 949-6080
Send inquiries to: email@example.com
Follow us at twitter and facebook
1. Berman BM, Langevin HM, Witt CM, et al. Acupuncture for Chronic Low Back Pain. N Engl J Med 2010; 363:454-461.
2. Cassileth BR, Deng GE, Gomez JE, et al. Complementary therapies and
integrative oncology in lung cancer: ACCP evidence-based clinical
practice guidelines (2nd ed). Chest 2007;132(3 Suppl):340S-354S.
3. Li S, Yu B, Zhou D, et al. Acupuncture for Attention Deficit Hyperactivity Disorder (ADHD) in children and adolescents. Cochrane Database Syst Rev 2011 Apr 13;4:CD007839.
4. Shaw KS, Bower KS, Mines MJ,et al. Does acupuncture treatment benefit dry eye? Invest Ophthalmol Vis Sci 2011; 52 (6): E-abstract 3839.
5. Hom MM. False staining appearance with lissamine green. Invest Ophthalmol Vis Sci 2011; 52 (6): E-abstract 1968.
6. Ocasio MA, Galor A, Zheng DD, et al. Trends in dry eye medication
use and expenditures: Medical expenditure panel survey 2001 - 2006. Invest Ophthalmol Vis Sci 2011; 52 (6): E-abstract 5529.
7. Chi SL, Acquah K, Richard MJ, et al. Relation between punctual plug usage and reimbursement amongst medicare beneficiaries. Invest Ophthalmol Vis Sci 2011; 52 (6): E-abstract 3852.
8. Mudgil P. Effect of hyperosmolarity on the antimicrobial properties of tear proteins. Invest Ophthalmol Vis Sci 2011; 52 (6): E-abstract 1486.
9. Foulks GN, Borchman D, Yappert MC. Comparative effectiveness of
azithromycin and doxycycline in therapy of meibomian gland dysfunction. Invest Ophthalmol Vis Sci 2011; 52 (6): E-abstract 3816.
10. Bickle KM, Nichols KK, Haque R, et al. Efficacy of topical
azithromycin ophthalmic solution 1.0% in the treatment of contact
lens-related dry eye. Invest Ophthalmol Vis Sci 2011; 52 (6): E-abstract 3842.
11. Senba K, Miyamoto T, Eguchi H, et al. The efficacy of oral
pilocarpine for the treatment of dry eye symptoms in patients with
aqueous tear deficiency and evaporative dry eye. Invest Ophthalmol Vis Sci 2011; 52 (6): E-abstract 3837.
12. Miyamoto T, Eguchi H, Mitamura Y. An original administration of oral pilocarpine (Salagen tablet 5 mg) for dry eye. Invest Ophthalmol Vis Sci 2011; 52 (6): E-abstract 3835.
13. Labbe A, Brasnu E, Van Went C, et al. Tear film osmolarity in patients treated for glaucoma or ocular hypertension. Invest Ophthalmol Vis Sci 2011; 52 (6): E-abstract 218.
14. VanWent C, Alalwani H, Brasnu E, et al. Corneal sensitivity in patients treated for glaucoma or ocular hypertension. Invest Ophthalmol Vis Sci 2011; 52 (6): E-abstract 257.